ProShares UltraShort NASDAQ Biotechnology
7 hedge funds and large institutions have $1.88M invested in ProShares UltraShort NASDAQ Biotechnology in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OMC
1
Old Mission Capital
Chicago,
Illinois
|
$776K |
| 2 |
2
IMC Chicago
Chicago,
Illinois
|
$450K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$252K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$33K |
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$366K |
| 2 |
2
Morgan Stanley
New York
|
$4K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
OMC
1
Old Mission Capital
Chicago,
Illinois
| $776K | 32,206 | +18,949 | +143% |
|
|
2
IMC Chicago
Chicago,
Illinois
| $450K | 18,668 | +18,668 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $366K | 15,178 | -4,606 | -23% |
|
|
4
Citadel Advisors
Miami,
Florida
| $252K | 10,471 | +10,471 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $33K | 1,371 | +485 | +55% |
|
|
6
Morgan Stanley
New York
| $4K | 183 | -198 | -52% |
|
7
Citigroup
New York
| $2K | 85 | – | – |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|